参考文献:
1.Niels H?iby, Helle Krogh Johansen, Claus Moser, Oana Ciofu, Peter ?strup Jensen, Mette Kolpen, Lotte Mandsberg, Michael Givskov, S?ren Molin, and Thomas Bjarnsholt. Pseudomonas aeruginosa Biofilms in the Lungs of Cystic Fibrosis Patients. Biofilm Infections. 167-184 (Chapter 10)
2.Ana Margarida Sousa , Maria Olívia Pereira . Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review. Pathogens 2014, 3, 680-703
3.Lawrence R. Mulcahy, Vincent M. Isabella, and Kim Lewis. Pseudomonas aeruginosa biofilms in disease. Microb Ecol. 2014 July ; 68(1): 1–12
4.Kunn Hadinoto?, WeanSinCheow Nano-antibiotics inchroniclunginfectiontherapyagainst Pseudomonas aeruginosa. Colloids and Surfaces B: Biointerfaces 116 (2014) 772–785
5.Hendricks MR, Lashua LP, Fischer DK, Flitter BA, Eichinger KM, Durbin JE, Sarkar SN, Coyne CB, Empey KM, Bomberger JM. Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity. Proc Natl Acad Sci US . 2016 Feb 9;113(6):1642-7
6.Daniel J. Hassett, Michael T. Borchers,and Ralph J. Panos. Chronic Obstructive Pulmonary Disease (COPD): Evaluation From Clinical, Immunological and Bacterial Pathogenesis Perspectives. J of Microbiology (2014) Vol. 52, No. 3, pp. 211–226